Testicular tumors

Last updated: July 21, 2022

Summarytoggle arrow icon

Testicular tumors most commonly occur in men between 20 and 35 years of age, and are the most common solid malignancy in this group. Most often, patients present with a painless nodule or swelling of the testis. Diagnosis is made primarily based on palpation and findings on testicular ultrasound. Diagnostic staging further includes an abdominopelvic and chest CT, determination of serologic tumor markers (AFP, HCG, LDH), and radical inguinal orchiectomy of the affected side to confirm the diagnosis and to evaluate the histopathology (seminoma vs. nonseminoma). The necessity and choice of adjuvant treatment depends on tumor pathology, staging, and prognosis. Treatment options include active surveillance, retroperitoneal radiotherapy, retroperitoneal lymph node dissection, and platinum-based chemotherapy. The overall prognosis of testicular tumors is excellent; patients can often be cured even in advanced, metastatic stages.

Epidemiologytoggle arrow icon

  • Most common solid malignant tumor in young men in the US
  • Peak incidence: 20–35 years; (nonseminomas peak in the third decade, seminomas in the fourth decade of life)


Epidemiological data refers to the US, unless otherwise specified.

Etiologytoggle arrow icon


Classificationtoggle arrow icon

Testicular tumors are classified according to pathology.

Overview of testicular tumors
Type of tumor Frequency AFP HCG Characteristics Pathology
Germ cell tumors of the testis (95%)
  • ∼ 40%
  • –/↑
Nonseminoma tumors Embryonal carcinoma
  • ∼ 25%
  • –/↑
  • Macroscopic findings: grey-white regressive changes with hemorrhage, necrosis, and cysts
  • Microscopy: glandular or papillary pattern
  • ∼ 25%
  • –/↑
  • Rare in adults, but common in children
  • Typically benign but may be malignant in adults (teratocarcinoma)
  • Composed of tissue from different germinal layers.
  • May be immature or may contain fully differentiated elements of muscle, cartilage, bone, teeth in mature teratomas
Testicular choriocarcinoma
  • ∼ 5%
  • ↑↑
Yolk sac tumor
  • ∼ 5%
  • ↑↑
  • Most common prepubertal testicular tumor [5]
  • Aggressive tumor with high malignant potential
Mixed germ cell tumors
  • ∼ 30% [6]
  • –/↑
  • –/↑
  • Heterogeneous cut surface with solid areas, hemorrhage, and necrosis
Non-germ cell tumors of the testis (5%)
Leydig cell tumors
  • ∼ 2%
  • Gross: characteristic golden brown color
  • Microscopy: Reinke crystals (eosinophilic cytoplasmic inclusions)
Sertoli cell tumors
  • < 1%
Secondary testicular tumors Lymphoma
  • Most common testicular tumor in men > 60 years of age

HCG is always elevated in choriocarcinoma and sometimes elevated in seminoma. AFP is always elevated in yolk sac tumors. Both AFP and HCG may be elevated in mixed germ cell tumors.

Testicular tumors metastasize early into the retroperitoneum via the lymphatic system (drain to the para-aortic lymph nodes first), with the exception of early hematogenous metastasizing choriocarcinomas.


Clinical featurestoggle arrow icon

Until proven otherwise, a firm nodule on the testis should be considered cancer!


Subtypes and variantstoggle arrow icon

Extragonadal germ cell tumors


Stagestoggle arrow icon

Staging of testicular tumors is based on the American Joint Committee on Cancer (AJCC) groups, which combines TNM stage and serum tumor marker levels.

Simplified AJCC classification
Stage Description
Stage I
Stage II
Stage III

Diagnosticstoggle arrow icon

Suspicion of a testicular tumor is usually established based on the clinical findings and ultrasound (to localize the tumor).

If a testicular tumor is suspected, the testis should be removed and sent to pathology. Transscrotal biopsy should not be conducted because of the risk of tumor seeding!


Differential diagnosestoggle arrow icon

Differential diagnosis of painless testicular swelling
Condition Clinical features Ultrasound
Testicular tumor
  • Usually painless mass (however, may feel dull ache or "heavy" sensation in the testicle)
  • Palpation of solid mass
  • Negative transillumination test
Hydrocele testis
Varicocele testis
  • Usually painless ; swelling may be reduced when supine
  • Visible or palpable strands and “bag of worms” sensation
  • Negative transillumination test
Spermatocele testis
Scrotal hernia
  • Herniated bowels


The differential diagnoses listed here are not exhaustive.

Treatmenttoggle arrow icon


Adjuvant radiotherapy and chemotherapy

Adjuvant treatment for testicular cancer
Staging according to the classification Seminoma Nonseminoma
Stage I

Stage II

Stage III
  • Chemotherapy (depending on prognosis): BEP1 or EP2 followed by evaluation of any residual disease that may require resection
1BEP = chemotherapy with bleomycin, etoposide, and cisplatin, 2EP = chemotherapy with etoposide, cisplatin, 3RPLND= retroperitoneal lymph node dissection


Prognosistoggle arrow icon

  • The overall prognosis of testicular tumors is excellent, with a high cure rate and 5-year survival rates of > 95%.
  • Even in advanced, metastatic stages, testicular tumors are often curable.

Testicular tumors, particularly seminomas, are one of the few cancers that can be cured even in very advanced stages with adequate treatment. Patients with nonseminomas have a significantly poorer prognosis but still an excellent overall survival rate!

Referencestoggle arrow icon

  1. Albers P, Albrecht W, Algaba F, et al. Guidelines on Testicular Cancer: 2015 Update. Eur Urol. 2015; 68 (6): p.1054-68.doi: 10.1016/j.eururo.2015.07.044 . | Open in Read by QxMD
  2. Michaelson MD, Oh WK. Epidemiology of and risk factors for testicular germ cell tumors. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: January 10, 2017. Accessed: March 5, 2017.
  3. Berney DM, Looijenga LH, Idrees M, et al. Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy. Histopathology. 2016; 69 (1): p.7-10.doi: 10.1111/his.12958 . | Open in Read by QxMD
  4. Testicular Cancer. Updated: February 12, 2016. Accessed: March 5, 2017.
  5. Kaatsch P, Häfner C, Calaminus G, Blettner M, Tulla M. Pediatric Germ Cell Tumors From 1987 to 2011: Incidence Rates, Time Trends, and Survival. Pediatrics. 2014; 135 (1): p.e136-e143.doi: 10.1542/peds.2014-1989 . | Open in Read by QxMD
  6. Trabert B, Stang A, Cook MB, Rusner C, McGlynn KA. Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma. Int J Androl. 2011; 34 (4pt2): p.e274-e277.doi: 10.1111/j.1365-2605.2011.01187.x . | Open in Read by QxMD
  7. Cheah CY, Wirth A, Seymour JF. Primary testicular lymphoma. Blood. 2014; 123 (4): p.486-493.doi: 10.1182/blood-2013-10-530659 . | Open in Read by QxMD
  8. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. McGraw-Hill Education ; 2015
  9. $Testicular cancer.
  10. $Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.
  11. Hirsch MS. Anatomy and pathology of testicular tumors. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: January 9, 2017. Accessed: March 5, 2017.
  12. Oosting SF, De haas EC, Links TP, et al. Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol. 2009; 21 (1): p.104-108.doi: 10.1093/annonc/mdp265 . | Open in Read by QxMD
  13. Marth D, Scheidegger J, Studer UE. Ultrasonography of Testicular Tumors. Urol Int. 1990; 45 (4): p.237-240.doi: 10.1159/000281715 . | Open in Read by QxMD
  14. Brenner JS, Ojo A. Causes of painless scrotal swelling in children and adolescents. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: May 9, 2016. Accessed: March 21, 2017.
  15. Steele GS, Richie JP, Oh WK, Michaelson MD. Clinical manifestations, diagnosis, and staging of testicular germ cell tumors. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: February 8, 2016. Accessed: February 15, 2017.
  16. Testicular Cancer Treatment (PDQ®): Health Professional Version. Updated: January 26, 2017. Accessed: February 15, 2017.
  17. Oh WK. Overview of the treatment of testicular germ cell tumors. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: January 18, 2017. Accessed: February 15, 2017.
  18. Cancer Stat Facts: Testis Cancer. Updated: March 5, 2017. Accessed: March 5, 2017.
  19. Goel P, Yadav D, Acharya S, Bagga D, Jain V, Dhua A. Sacrococcygeal teratoma: Clinical characteristics, management, and long-term outcomes in a prospective study from a Tertiary Care Center. Journal of Indian Association of Pediatric Surgeons. 2020; 25 (1): p.15.doi: 10.4103/jiaps.jiaps_219_18 . | Open in Read by QxMD
  20. Schmoll HJ. Extragonadal germ cell tumors. Ann Oncol. 2002; 13 (Suppl 4): p.265-272.doi: 10.1093/annonc/mdf669 . | Open in Read by QxMD
  21. Kantoff PW. Extragonadal germ cell tumors involving the mediastinum and retroperitoneum. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. Last updated: January 12, 2017. Accessed: March 5, 2017.
  22. Albany C, Einhorn LH. Extragonadal germ cell tumors: clinical presentation and management. Curr Opin Oncol. 2013; 25 (3): p.261-265.doi: 10.1097/CCO.0b013e32835f085d . | Open in Read by QxMD

Icon of a lock3 free articles remaining

You have 3 free member-only articles left this month. Sign up and get unlimited access.
 Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer